Nomura Holdings’s Oric Pharmaceuticals ORIC Stock Holding History

Nomura Holdings’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,512	Closed	-$282K	–	1960
2024 Q1	$282K	Buy	+20,512	New	+$244K	﹤0.01%	1377

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings's ORIC Position: Q2 2024 in Review

Nomura Holdings sold out of Oric Pharmaceuticals (ORIC) in Q2 2024, closing a stake of 20,512 shares — an estimated $282K sold.

Nomura Holdings first reported a position in ORIC in Q1 2024 and held it in 1 quarter. The position peaked at $282K in Q1 2024. 113 funds tracked by Wall St. Rank hold ORIC as of Q2 2024.

Nomura Holdings reported no remaining Oric Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Nomura Holdings sold 20,512 Oric Pharmaceuticals shares in Q2 2024, an estimated $282K.
Nomura Holdings first reported a position in Oric Pharmaceuticals in Q1 2024 and held it in 1 quarter.
Nomura Holdings's Oric Pharmaceuticals position peaked at $282K in Q1 2024.
113 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2024.

Based on Nomura Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.